Literature DB >> 22362053

New methods for clinical pathways-Business Process Modeling Notation (BPMN) and Tangible Business Process Modeling (t.BPM).

Hubert Scheuerlein1, Falk Rauchfuss, Yves Dittmar, Rüdiger Molle, Torsten Lehmann, Nicole Pienkos, Utz Settmacher.   

Abstract

PURPOSE: Clinical pathways (CP) are nowadays used in numerous institutions, but their real impact is still a matter of debate. The optimal design of a clinical pathway remains unclear and is mainly determined by the expectations of the individual institution. The purpose of the here described pilot project was the development of two CP (colon and rectum carcinoma) according to Business Process Modeling Notation (BPMN) and Tangible Business Process Modeling (t.BPM).
METHODS: BPMN is an established standard for business process modelling in industry and economy. It is, in the broadest sense, a computer programme which enables the description and a relatively easy graphical imaging of complex processes. t.BPM is a modular construction system of the BPMN symbols which enables the creation of an outline or raw model, e.g. by placing the symbols on a spread-out paper sheet. The thus created outline can then be transferred to the computer and further modified as required. CP for the treatment of colon and rectal cancer have been developed with support of an external IT coach.
RESULTS: The pathway was developed in an interdisciplinary and interprofessional manner (55 man-days over 15 working days). During this time, necessary interviews with medical, nursing and administrative staffs were conducted as well. Both pathways were developed parallel. Subsequent analysis was focussed on feasibility, expenditure, clarity and suitability for daily clinical practice. The familiarization with BPMN was relatively quick and intuitive. The use of t.BPM enabled the pragmatic, effective and results-directed creation of outlines for the CP. The development of both CP was finished from the diagnostic evaluation to the adjuvant/neoadjuvant therapy and rehabilitation phase. The integration of checklists, guidelines and important medical or other documents is easily accomplished. A direct integration into the hospital computer system is currently not possible for technical reasons.
CONCLUSION: BPMN and t.BPM are sufficiently suitable for the planned modelling and imaging of CP. The application in medicine is new, and transfer from the industrial process management is in principle possible. BPMN-CP may be used for teaching and training, patient information and quality management. The graphical image is clearly structured and appealing. Even though the efficiency in the creation of BPMN-CP increases markedly after the training phase, high amounts of manpower and time are required. The most sensible and consequent application of a BPMN-CP would be the direct integration into the hospital computer system. The integration of a modelling language, such as BPMN, into the hospital computer systems could be a very sensible approach for the development of new hospital information systems in the future.

Entities:  

Mesh:

Year:  2012        PMID: 22362053     DOI: 10.1007/s00423-012-0914-z

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  7 in total

Review 1.  Clinical Pathways in surgery: should we introduce them into clinical routine? A review article.

Authors:  Ulrich Ronellenfitsch; Eric Rössner; Jens Jakob; Stefan Post; Peter Hohenberger; Matthias Schwarzbach
Journal:  Langenbecks Arch Surg       Date:  2008-02-23       Impact factor: 3.445

2.  S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII).

Authors:  W Schmiegel; C Pox; A Reinacher-Schick; G Adler; D Arnold; W Fleig; U R Fölsch; P Frühmorgen; U Graeven; V Heinemann; W Hohenberger; A Holstege; T Junginger; I Kopp; T Kühlbacher; R Porschen; P Propping; J-F Riemann; C Rödel; R Sauer; T Sauerbruch; W Schmitt; H-J Schmoll; T Seufferlein; M Zeitz; H-K Selbmann
Journal:  Z Gastroenterol       Date:  2010-01-13       Impact factor: 2.000

Review 3.  Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs.

Authors:  Thomas Rotter; Leigh Kinsman; Erica James; Andreas Machotta; Holger Gothe; Jon Willis; Pamela Snow; Joachim Kugler
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

4.  What is a clinical pathway? Development of a definition to inform the debate.

Authors:  Leigh Kinsman; Thomas Rotter; Erica James; Pamela Snow; Jon Willis
Journal:  BMC Med       Date:  2010-05-27       Impact factor: 8.775

5.  Implementation of workflow engine technology to deliver basic clinical decision support functionality.

Authors:  Vojtech Huser; Luke V Rasmussen; Ryan Oberg; Justin B Starren
Journal:  BMC Med Res Methodol       Date:  2011-04-10       Impact factor: 4.615

6.  Implementation of the Business Process Modelling Notation (BPMN) in the modelling of anatomic pathology processes.

Authors:  Marcial García Rojo; Elvira Rolón; Luis Calahorra; Felix Oscar García; Rosario Paloma Sánchez; Francisco Ruiz; Nieves Ballester; María Armenteros; Teresa Rodríguez; Rafael Martín Espartero
Journal:  Diagn Pathol       Date:  2008-07-15       Impact factor: 2.644

7.  Standardization efforts of digital pathology in Europe.

Authors:  Marcial García Rojo; Christel Daniel; Thomas Schrader
Journal:  Anal Cell Pathol (Amst)       Date:  2012       Impact factor: 2.916

  7 in total
  14 in total

1.  Modeling a Clinical Pathway for Contraception.

Authors:  Letha J Sooter; Steve Hasley; Robert Lario; Kenneth S Rubin; Faruk Hasić
Journal:  Appl Clin Inform       Date:  2019-12-11       Impact factor: 2.342

Review 2.  Computer-assisted abdominal surgery: new technologies.

Authors:  H G Kenngott; M Wagner; F Nickel; A L Wekerle; A Preukschas; M Apitz; T Schulte; R Rempel; P Mietkowski; F Wagner; A Termer; Beat P Müller-Stich
Journal:  Langenbecks Arch Surg       Date:  2015-02-21       Impact factor: 3.445

3.  A Framework for Incorporating Patient Preferences to Deliver Participatory Medicine via Interdisciplinary Healthcare Teams.

Authors:  Craig Kuziemsky; Davood Astaraky; Szymon Wilk; Wojtek Michalowski; Pavel Andreev
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

4.  A Methodological Framework for the Integrated Design of Decision-Intensive Care Pathways-an Application to the Management of COPD Patients.

Authors:  Carlo Combi; Barbara Oliboni; Alessandro Zardini; Francesca Zerbato
Journal:  J Healthc Inform Res       Date:  2017-10-17

5.  Using Semantic Components to Represent Dynamics of an Interdisciplinary Healthcare Team in a Multi-Agent Decision Support System.

Authors:  Szymon Wilk; Mounira Kezadri-Hamiaz; Daniela Rosu; Craig Kuziemsky; Wojtek Michalowski; Daniel Amyot; Marc Carrier
Journal:  J Med Syst       Date:  2015-11-21       Impact factor: 4.460

6.  Mapping Patient Data to Colorectal Cancer Clinical Algorithms for Personalized Guideline-Based Treatment.

Authors:  Matthias Becker; Britta Böckmann; Karl-Heinz Jöckel; Martin Stuschke; Andreas Paul; Stefan Kasper; Isabel Virchow
Journal:  Appl Clin Inform       Date:  2020-03-18       Impact factor: 2.342

7.  Graphical modeling and query language for hospitals.

Authors:  Janis Barzdins; Juris Barzdins; Edgars Rencis; Agris Sostaks
Journal:  Health Inf Sci Syst       Date:  2013-11-04

8.  Leveraging workflow control patterns in the domain of clinical practice guidelines.

Authors:  Katharina Kaiser; Mar Marcos
Journal:  BMC Med Inform Decis Mak       Date:  2016-02-10       Impact factor: 2.796

9.  An Evaluation of Understandability of Patient Journey Models in Mental Health.

Authors:  Jennifer Percival; Carolyn McGregor
Journal:  JMIR Hum Factors       Date:  2016-07-28

10.  A meta-model for computer executable dynamic clinical safety checklists.

Authors:  Shan Nan; Pieter Van Gorp; Xudong Lu; Uzay Kaymak; Hendrikus Korsten; Richard Vdovjak; Huilong Duan
Journal:  BMC Med Inform Decis Mak       Date:  2017-12-12       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.